Drug archive
Haemophilus b Conjugate Vaccine (Systemic)Proper Use
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Proper Use of This Vaccine
Dosing - Haemophilus b conjugate vaccine is an haemophilus b vaccine that has been prepared by adding a diphtheria-, meningococcal-, or tetanus-related substance to it. If the vaccine was prepared using a diphtheria-related substance, it is called either HbOC or PRP-D. If the vaccine was prepared using a meningococcal-related substance, it is called PRP-OMP. If the vaccine was prepared using a tetanus-related substance, it is called PRP-T. All of these subtypes of haemophilus b conjugate vaccine work the same way , but may be given at different ages or times.
The dose of haemophilus b conjugate vaccine will be different for different patients. The following information includes only the average doses of haemophilus b conjugate vaccine.
-
For prevention of Haemophilus influenzae
type b infection:
-
For HbOC or PRP-T injection
dosage form:
- Adults and children 5 years of age and older - Use and dose must be determined by your doctor.
- Infants 2 to 6 months of age at the first dose - Three doses, two months apart, then a booster dose at fifteen months of age. The doses are injected into a muscle.
- Children 7 to 11 months of age at the first dose - Two doses, two months apart, then a booster dose at fifteen months of age. The doses are injected into a muscle.
- Children 12 to 14 months of age at the first dose - One dose, then a booster dose at fifteen months of age. The doses are injected into a muscle.
- Children 15 to 59 months of age at the first dose - One dose injected into a muscle.
-
For PRP-D injection
dosage form:
- Adults and children 5 years of age and older - Use and dose must be determined by your doctor.
- Infants and children up to 15 months of age - Use is not recommended.
- Children 15 to 59 months of age at the first dose - One dose injected into a muscle.
-
For PRP-OMP injection
dosage form:
- Adults and children 5 years of age and older - Use and dose must be determined by your doctor.
- Infants 2 to 6 months of age at the first dose - Two doses, two months apart, then a booster dose at twelve months of age. The doses are injected into a muscle.
- Children 7 to 11 months of age at the first dose - Two doses, two months apart, then a booster dose at fifteen months of age. The doses are injected into a muscle.
- Children 12 to 14 months of age at the first dose - One dose, then a booster dose at fifteen months of age. The doses are injected into a muscle.
- Children 15 to 59 months of age at the first dose - One dose injected into a muscle.
-
For HbOC or PRP-T injection
dosage form: